The results are also supported by a recent meta-analysis of 45 RCTs, including more than 250,000 patients, which showed that both high-intensity (RR of 0.84, 95% CI of 0.70–1.02) and low-intensity statin monotherapy were associated with a positive trend toward VTE risk reduction (RR for high-intensity of 0.84, 95% CI of 0.70–1.02; RR for low-intensity of 0.89, 95% CI of 0.79–1.00) [ 122 ].
← all excerpts
Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications.
1
—
—